HCC Staging Modified by Tumor Micronecrosis

CompletedOBSERVATIONAL
Enrollment

1,100

Participants

Timeline

Start Date

July 15, 2022

Primary Completion Date

December 1, 2022

Study Completion Date

January 15, 2023

Conditions
Hepatocellular Carcinoma
Interventions
BEHAVIORAL

tumor micronecrosis

whether HCC patients have tumor micronecrosis or not

Trial Locations (2)

310003

the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

310009

the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
collaborator

Huizhou Municipal Central Hospital

OTHER

collaborator

Second Affiliated Hospital of Nanchang University

OTHER

collaborator

Meng Chao Hepatobiliary Hospital of Fujian Medical University

OTHER

lead

Zhejiang University

OTHER